1. Home
  2. EMBC vs CTLP Comparison

EMBC vs CTLP Comparison

Compare EMBC & CTLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • CTLP
  • Stock Information
  • Founded
  • EMBC 1924
  • CTLP 1992
  • Country
  • EMBC United States
  • CTLP United States
  • Employees
  • EMBC N/A
  • CTLP 375
  • Industry
  • EMBC Medical/Dental Instruments
  • CTLP EDP Services
  • Sector
  • EMBC Health Care
  • CTLP Technology
  • Exchange
  • EMBC Nasdaq
  • CTLP Nasdaq
  • Market Cap
  • EMBC 788.4M
  • CTLP 797.4M
  • IPO Year
  • EMBC N/A
  • CTLP N/A
  • Fundamental
  • Price
  • EMBC $14.38
  • CTLP $10.87
  • Analyst Decision
  • EMBC Buy
  • CTLP Hold
  • Analyst Count
  • EMBC 2
  • CTLP 5
  • Target Price
  • EMBC $19.00
  • CTLP $11.50
  • AVG Volume (30 Days)
  • EMBC 741.6K
  • CTLP 2.1M
  • Earning Date
  • EMBC 08-08-2025
  • CTLP 09-09-2025
  • Dividend Yield
  • EMBC 4.17%
  • CTLP N/A
  • EPS Growth
  • EMBC 18.26
  • CTLP 404.65
  • EPS
  • EMBC 1.42
  • CTLP 0.80
  • Revenue
  • EMBC $1,102,500,000.00
  • CTLP $292,642,000.00
  • Revenue This Year
  • EMBC N/A
  • CTLP $15.44
  • Revenue Next Year
  • EMBC N/A
  • CTLP $15.82
  • P/E Ratio
  • EMBC $10.12
  • CTLP $13.59
  • Revenue Growth
  • EMBC N/A
  • CTLP 12.51
  • 52 Week Low
  • EMBC $9.20
  • CTLP $5.82
  • 52 Week High
  • EMBC $21.48
  • CTLP $11.36
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 73.57
  • CTLP 45.47
  • Support Level
  • EMBC $13.35
  • CTLP $10.83
  • Resistance Level
  • EMBC $14.09
  • CTLP $10.96
  • Average True Range (ATR)
  • EMBC 0.61
  • CTLP 0.06
  • MACD
  • EMBC 0.21
  • CTLP -0.04
  • Stochastic Oscillator
  • EMBC 91.40
  • CTLP 25.81

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About CTLP Cantaloupe Inc.

Cantaloupe Inc operates in the small ticket electronic payments industry. It provides wireless, cashless, micro-transactions, and networking services within the unattended Point of Sale (POS) market. Its products and services portfolio consists of ePort Cashless devices, eSuds, EnergyMisers, and Value-added services which include Loyalty and Prepaid, Intelligent Vending, and others. The company offers services to different industries covering car wash, taxi and transportation, laundry, vending, kiosk, amusement, and arcade. The company derives revenue from the sale or lease of equipment and services to the small ticket, unattended POS market, and the majority of its revenue is derived from subscription and transaction fees.

Share on Social Networks: